Berliner Boersenzeitung - Natural immunity more potent than vaccines during US Delta wave: study

EUR -
AED 4.125482
AFN 71.893569
ALL 91.0039
AMD 404.558002
ANG 2.010545
AOA 1030.107049
ARS 1735.583297
AUD 1.619807
AWG 2.024828
AZN 1.910204
BAM 1.958466
BBD 2.263281
BDT 139.960554
BGN 1.963416
BHD 0.424164
BIF 3358.231968
BMD 1.123344
BND 1.434579
BOB 13.568473
BRL 6.183791
BSD 1.12373
BTN 106.108465
BWP 15.39496
BYN 3.352865
BYR 22017.550536
BZD 2.259977
CAD 1.57435
CDF 2600.542712
CHF 0.915868
CLF 0.027919
CLP 1098.822164
CNY 7.513489
CNH 7.486495
COP 3640.051542
CRC 509.577905
CUC 1.123344
CUP 26.968717
CVE 110.417297
CZK 24.332089
DJF 200.102436
DKK 7.474515
DOP 67.47977
DZD 152.90291
EGP 60.551405
ERN 16.850166
ETB 184.424845
FJD 2.531232
FKP 0.834686
GBP 0.834538
GEL 2.926316
GGP 0.834686
GHS 13.107846
GIP 0.834686
GMD 83.70208
GNF 9953.241063
GTQ 8.587845
GYD 235.440548
HKD 8.804768
HNL 30.201177
HRK 7.60393
HTG 147.273132
HUF 364.247802
IDR 20312.59455
ILS 3.596107
IMP 0.834686
INR 106.111844
IQD 1703.519314
IRR 2124640.828982
ISK 136.811552
JEP 0.834686
JMD 178.232661
JOD 0.796453
JPY 176.953143
KES 145.923453
KGS 98.235688
KHR 4572.306526
KMF 495.394853
KPW 1011.00993
KRW 1523.687494
KWD 0.348877
KYD 0.936475
KZT 505.2579
LAK 25290.432511
LBP 100627.803113
LKR 373.578621
LRD 191.030084
LSL 18.415172
LTL 3.316944
LVL 0.6795
LYD 7.193794
MAD 10.950909
MDL 20.091354
MGA 5094.936673
MKD 61.583069
MMK 2358.849304
MNT 4045.672704
MOP 9.080062
MRU 45.396392
MUR 52.516314
MVR 17.361247
MWK 1948.552923
MXN 21.089904
MYR 4.546283
MZN 71.792986
NAD 18.415172
NGN 1511.044247
NIO 41.355016
NOK 10.443256
NPR 169.767847
NZD 2.007709
OMR 0.431927
PAB 1.12373
PEN 3.87057
PGK 5.11881
PHP 70.830279
PKR 310.788734
PLN 4.40337
PYG 6923.426132
QAR 4.107666
RON 5.336228
RSD 117.599566
RUB 91.557495
RWF 1655.253601
SAR 4.216259
SBD 9.044852
SCR 15.559092
SDG 675.690666
SEK 11.0154
SGD 1.435527
SHP 0.837504
SLE 25.735739
SLL 23555.975653
SOS 642.17431
SRD 42.18947
STD 23250.961369
STN 24.532636
SVC 9.832387
SYP 14605.723731
SZL 18.408062
THB 37.566904
TJS 10.366213
TMT 3.942939
TND 3.348519
TOP 2.704743
TRY 56.343251
TTD 7.610361
TWD 37.208531
TZS 2968.433722
UAH 51.044897
UGX 4545.1882
USD 1.123344
UYU 45.26243
UZS 13409.256484
VES 1004.010383
VND 28850.292941
VUV 134.41388
WST 3.126448
XAF 655.957
XAG 0.021615
XAU 0.000273766094
XCD 3.035895
XCG 2.025157
XDR 0.794263
XOF 655.957
XPF 119.331742
YER 265.305896
ZAR 18.508674
ZMK 10111.448972
ZMW 22.783019
ZWL 361.716443
SSP 6454.193881
MXV 2.373304
  • CMSD

    -0.1200

    19.81

    -0.61%

  • JRI

    0.0000

    10.77

    0%

  • BCC

    -1.8200

    74.15

    -2.45%

  • CMSC

    -0.2228

    19.53

    -1.14%

  • BCE

    0.2000

    20.34

    +0.98%

  • RIO

    0.0100

    94.17

    +0.01%

  • AZN

    -2.7400

    161.47

    -1.7%

  • GSK

    -1.1800

    48.17

    -2.45%

  • RBGPF

    0.0000

    65

    0%

  • NGG

    0.8800

    75.82

    +1.16%

  • RYCEF

    -0.7300

    19.08

    -3.83%

  • BTI

    -0.4500

    54.4

    -0.83%

  • BP

    0.4700

    43.99

    +1.07%

  • RELX

    -0.0600

    33.18

    -0.18%

  • VOD

    -0.1800

    16.15

    -1.11%

Natural immunity more potent than vaccines during US Delta wave: study
Natural immunity more potent than vaccines during US Delta wave: study

Natural immunity more potent than vaccines during US Delta wave: study

During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.

Text size:

The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).

The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.

Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.

"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.

"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.

The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.

It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.

Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.

- Selection bias? -

By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.

In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.

Protection was highest among those who had both vaccination and prior Covid.

The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.

Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.

But the US CDC had previously taken the opposite position, based on pre-Delta data.

"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.

(G.Gruner--BBZ)